Anti-inflammatory compounds and compositions

Details Anti-inflammatory compounds and compositions Anti-inflammatory compounds and compositions

2007-08-02

2010-02-16

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S315000

Reexamination Certificate

active

07662967

ABSTRACT:
The invention relates to the use of 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one for preparing a medicament intended to prevent or treat inflammatory disorders.

REFERENCES:
patent: 5593827 (1997-01-01), Bycroft et al.
patent: 5776974 (1998-07-01), Bycroft et al.
patent: 5969158 (1999-10-01), Bycroft et al.
patent: 6395282 (2002-05-01), Kende et al.
patent: 6602905 (2003-08-01), Gardiner et al.
patent: 2002/0025957 (2002-02-01), Stein et al.
patent: 2006/0233728 (2006-10-01), Sagawa et al.
patent: 0519877 (1992-12-01), None
patent: 0443588 (1999-06-01), None
patent: 1374365 (1974-11-01), None
patent: 10265761 (1998-10-01), None
patent: WO-8910961 (1989-11-01), None
patent: WO-9501175 (1995-01-01), None
patent: WO-9825951 (1998-06-01), None
patent: WO-9912933 (1999-03-01), None
patent: WO-9912968 (1999-03-01), None
patent: WO-9927786 (1999-06-01), None
patent: WO-9931506 (1999-06-01), None
patent: WO-9931507 (1999-06-01), None
patent: WO-0035871 (2000-06-01), None
patent: WO-0126650 (2001-04-01), None
patent: WO-0168655 (2001-09-01), None
patent: WO-02052949 (2002-07-01), None
patent: WO-2004022536 (2004-03-01), None
patent: WO-2005053702 (2005-06-01), None
patent: WO-2005075439 (2005-08-01), None
patent: WO-2006016152 (2006-02-01), None
patent: WO-2006018609 (2006-02-01), None
patent: WO-2006024815 (2006-03-01), None
patent: WO-2006076442 (2006-07-01), None
patent: WO-2006085096 (2006-08-01), None
patent: WO-2006134378 (2006-12-01), None
patent: WO-2006134384 (2006-12-01), None
patent: WO-2006134385 (2006-12-01), None
“International Application No. PCT/GB2006/002218 International Preliminary Report on Patentability mailed May 30, 2007”, 9 pgs.
“International Application No. PCT/GB2006/002218 International Search Report and Written Opinion mailed Dec. 14, 2006”, 19 pgs.
“United Kingdom Application No. GB0512238.7 Search Report mailed Sep. 12, 2005”, 3 pgs.
Batrakov, S. G., et al., “A New Ornithine-Containing Lipid From Actinomyces No. 660-15”,Chemistry of Natural Compounds8(2), (Mar. 1974),153-158.
Clarke, D. R., et al., “Synthesis and Mass Spectra of Some 3-Acylamino-2-piperidones”,J. Chem. Soc. C: Organic, (1971),3743-3748.
Cotman, Carl W., et al., “A Potential Role for Apoptosis in Neurodegeneration and Alzheimer's Disease”,Molecular Neurobiology10(1), (1995), 19-45.
Fox, David J., et al., “Design, Synthesis, and Preliminary Pharmacological Evaluation of N-Acyl-3-aminoglutarimides as Broad-Spectrum Chemokine Inhibitors in Vitro and Anti-inflammatory Agents in Vivo”,J. Med. Chem. 45, (2002), 360-370.
Fox, David J., et al., “Identification of 3-(Acylamino) azepan-2-ones as as Stable Broad-Spectrum Chemokine Inhibitors Resistant to Metabolism in Vivo”,J. Med. Chem48, (2005),867-874.
Fringuelli, Renata , et al., “Synthesis and evaluation of anti-apoptotic activity of L-carnitine cyclic analogues and amino acid derivatives”,IL FARMACO59(4), (Apr. 4, 2004),271-277.
Frow, Emma K., et al., “Tools for Anti-Inflammatory Drug Design: In Vitro Models of Leukocyte Migration”,Medicinal Research Reviews24(3), (2004),267-298.
Gao, Xuri , et al., “Catalytic Asymmetric Synthesis of a Potent Thiomarinol Antibiotic”,J. Am. Chem. Soc. 127(6), (Feb. 16, 2005),1628-1629.
Grainger, David J., et al., “Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo”,Biochemical Pharmacology65, (2003),1027-1034.
Jiao, Ying , et al., “Structural Identification of Cepaciamide A, a Novel Fungitoxic Compound fromPseudomonas cepaciaD-202”,Tetrahedron Letters37(7), (1996),1039-1042.
Reckless, Jill , et al., “Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines”,Biochem. J. 340, (1999),803-811.
Reckless, Jill , et al., “The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-a accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo”,Immunology103(2), (2001),244-254.
Schreiber, J. , et al., “The Reaction of Cyanogen Bromide with Mono- and Diamino Acids”,Journal of the American Chemical Society86(12), (Jun. 20, 1964),2441-2445.
Gould, Philip L., “Salt selection for basic drugs”,International Journal of Pharmaceutics33, (1986),201-217.
Grainger, David J., et al., “Broad spectrum chemokine inhibitors related to NR58-3.14.3”,Mini-Reviews in Medicinal Chemistry5, (2005),825-832.

Affiliated with

Also associated with

Rating

Anti-inflammatory compounds and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-inflammatory compounds and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory compounds and compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4179178